Production of pseudoinfectious yellow fever virus with a two-component genome

被引:44
作者
Shustov, Alexandr V.
Mason, Peter W.
Frolov, Ilya
机构
[1] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Pathol, Galveston, TX 77555 USA
[3] Univ Texas, Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA
关键词
D O I
10.1128/JVI.01112-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Application of genetically modified, deficient-in-replication flaviviruses that are incapable of developing productive, spreading infection is a promising means of designing safe and effective vaccines. Here we describe a two-component genome yellow fever virus (YFV) replication system in which each of the genomes encodes complete sets of nonstructural proteins that form the replication complex but expresses either only capsid or prM/E instead of the entire structural polyprotein. Upon delivery to the same cell, these genomes produce together all of the viral structural proteins, and cells release a combination of virions with both types of genomes packaged into separate particles. In tissue culture, this modified YFV can be further passaged at an escalating scale by using a high multiplicity of infection (MOI). However, at a low MOI, only one of the genomes is delivered into the cells, and infection cannot spread. The replicating prM/E-encoding genome produces extracellular E protein in the form of secreted subviral particles that are known to be an effective immunogen. The presented strategy of developing viruses defective in replication might be applied to other flaviviruses, and these two-component genome viruses can be useful for diagnostic or vaccine applications, including the delivery and expression of heterologous genes. In addition, the achieved separation of the capsid-coding sequence and the cyclization signal in the YFV genome provides a new means for studying the mechanism of the flavivirus packaging process.
引用
收藏
页码:11737 / 11748
页数:12
相关论文
共 41 条
[1]   Humoral and cellular immune response to RNA immunization with flavivirus Replicons derived from tick-borne encephalitis virus [J].
Aberle, JH ;
Aberle, SW ;
Kofler, RA ;
Mandl, CW .
JOURNAL OF VIROLOGY, 2005, 79 (24) :15107-15113
[2]  
Aberle JH, 1999, J IMMUNOL, V163, P6756
[3]  
[Anonymous], FIELDS VIROLOGY
[4]   A stable full-length yellow fever virus cDNA clone and the role of conserved RNA elements in flavivirus replication [J].
Bredenbeek, PJ ;
Kooi, EA ;
Lindenbach, B ;
Huijkman, N ;
Rice, CM ;
Spaan, WJM .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :1261-1268
[5]   SINDBIS VIRUS EXPRESSION VECTORS - PACKAGING OF RNA REPLICONS BY USING DEFECTIVE HELPER RNAS [J].
BREDENBEEK, PJ ;
FROLOV, I ;
RICE, CM ;
SCHLESINGER, S .
JOURNAL OF VIROLOGY, 1993, 67 (11) :6439-6446
[6]   Yellow fever Japanese encephalitis chimeric viruses: Construction and biological properties [J].
Chambers, TJ ;
Nestorowicz, A ;
Mason, PW ;
Rice, CM .
JOURNAL OF VIROLOGY, 1999, 73 (04) :3095-3101
[7]   DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus [J].
Colombage, G ;
Hall, R ;
Pavy, M ;
Lobigs, M .
VIROLOGY, 1998, 250 (01) :151-163
[8]   West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays [J].
Davis, BS ;
Chang, GJJ ;
Cropp, B ;
Roehrig, JT ;
Martin, DA ;
Mitchell, CJ ;
Bowen, R ;
Bunning, ML .
JOURNAL OF VIROLOGY, 2001, 75 (09) :4040-4047
[9]   Sindbis virus with a tricomponent genome [J].
Fayzulin, R ;
Gorchakov, R ;
Petrakova, O ;
Volkova, E ;
Frolov, I .
JOURNAL OF VIROLOGY, 2005, 79 (01) :637-643
[10]   Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines [J].
Fayzulin, Rafik ;
Scholle, Frank ;
Petrakova, Olga ;
Frolov, Ilya ;
Mason, Peter W. .
VIROLOGY, 2006, 351 (01) :196-209